(Q51557015)
Statements
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). (English)
1 reference
D Matecka
1 reference
R B Rothman
1 reference
L Radesca
1 reference
B R de Costa
1 reference
C M Dersch
1 reference
J S Partilla
1 reference
A Pert
1 reference
J R Glowa
1 reference
F H Wojnicki
1 reference
K C Rice
1 reference
1 November 1996
1 reference
39
1 reference
24
1 reference
4704-4716
1 reference